Cervical Adenosquamous Cell Carcinoma Withdrawn Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Cervical Adenosquamous Carcinoma / Adenosquamous carcinoma of the cervix / Adenosquamous carcinoma of cervix (disorder)

IndicationStatusPhase
DBCOND0034091 (Cervical Adenosquamous Cell Carcinoma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03834571Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenTreatment